TECX (Tectonic Therapeutic) Float Percentage Of Total Shares Outstanding: 49.45% (As of Aug. 13, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TECX Tectonic Therapeutic Inc TECX
14 GF Score
Price $33.98
! 3 Warning Signs
View Full Analysis

What is Tectonic Therapeutic Float Percentage Of Total Shares Outstanding?

Tectonic Therapeutic TECX -7.84% 14 Float Percentage Of Total Shares Outstanding is 49.45% as of Aug. 13, 2026. GuruFocus rates TECX with a GF Score™ of 14/100. The stock has 3 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Tectonic Therapeutic's float shares is 9.67 Mil. Tectonic Therapeutic's total shares outstanding is 19.55 Mil. Tectonic Therapeutic's float percentage of total shares outstanding is 49.45%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Tectonic Therapeutic's Insider Ownership is 26.68%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Tectonic Therapeutic's Institutional Ownership is 73.22%.

TECX
14GF Score
Tectonic Therapeutic Inc TECX
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tectonic Therapeutic Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Tectonic Therapeutic's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=9.67/19.55
=49.45%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 49.45% mean?
Tectonic Therapeutic (TECX) has a Float Percentage Of Total Shares Outstanding of 49.45% as of Aug. 13, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Tectonic Therapeutic and its competitors.
Is Tectonic Therapeutic's Float Percentage Of Total Shares Outstanding too high?
Tectonic Therapeutic's current Float Percentage Of Total Shares Outstanding is 49.45%. Overall, Tectonic Therapeutic has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Tectonic Therapeutic's Float Percentage Of Total Shares Outstanding compare to ZVRA and SPRY?
Tectonic Therapeutic's Float Percentage Of Total Shares Outstanding of 49.45% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Tectonic Therapeutic and its competitors. Tectonic Therapeutic's current Float Percentage Of Total Shares Outstanding is 49.45%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tectonic Therapeutic stock overvalued right now?
Tectonic Therapeutic (TECX) has a current Float Percentage Of Total Shares Outstanding of 49.45%. The current Float Percentage Of Total Shares Outstanding is 49.45%. Tectonic Therapeutic's overall GF Score™ is 14/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Tectonic Therapeutic (TECX), the current Float Percentage Of Total Shares Outstanding is 49.45% as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tectonic Therapeutic Business Description

Address 490 Arsenal Way, Suite 210, Watertown, MA, USA, 02472
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
14GF Score

Get the complete analysis for TECX

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$33.98
Price